1.1. Research Objective

1.2. Product Overview

1.3. Market Segmentation

2.1. Qualitative Research
2.1.1. Primary & Secondary Sources

2.2. Quantitative Research
2.2.1. Primary & Secondary Sources

2.3. Breakdown of Primary Research Respondents, By Region

2.4. Assumption for the Study

2.5. Market Size Estimation

2.6. Data Triangulation

Executive Summary: Global Organoids and Spheroids Market 

4.1. Industry Value Chain Analysis
4.1.1. Manufacturers
4.1.2. Providers
4.1.3. End User

4.2. Industry Outlook

4.3. PESTLE Analysis

4.4. Porter's Five Forces Analysis
4.4.1. Bargaining Power of Suppliers
4.4.2. Bargaining Power of Buyers
4.4.3. Threat of Substitutes
4.4.4. Threat of New Entrants
4.4.5. Degree of Competition

4.5. Market Dynamics and Trends
4.5.1. Growth Drivers
4.5.2. Restraints
4.5.3. Challenges
4.5.4. Key Trends

4.6. Covid-19 Impact Assessment on Market Growth Trend

4.7. Market Growth and Outlook
4.7.1. Market Revenue Estimates and Forecast (US$ Mn), 2019 - 2032
4.7.2. Price Trend Analysis

4.8. Competition Dashboard
4.8.1. Market Concentration Rate
4.8.2. Company Market Share Analysis (Value %), 2023
4.8.3. Competitor Mapping

5.1. Key Insights

5.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
5.2.1. Organoids
5.2.1.1. Neural Organoids
5.2.1.2. Hepatic Organoids
5.2.1.3. Intestinal Organoids
5.2.1.4. Kidney Organoids
5.2.1.5. Other Organoids
5.2.2. Spheroids
5.2.2.1. Multicellular tumor spheroids (MCTS)
5.2.2.2. Neurospheres
5.2.2.3. Mammospheres
5.2.2.4. Hepatospheres
5.2.2.5. Embryoid bodies

6.1. Key Insights

6.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
6.2.1. Organoids
6.2.1.1. General Submerged Method for Organoid Culture
6.2.1.2. Crypt Organoid Culture Techniques
6.2.1.3. Air Liquid Interface (ALI) Method for Organoid Culture
6.2.1.4. Clonal Organoids from Lgr5+ Cells
6.2.1.5. Brain and Retina Organoid Formation Protocol
6.2.2. Spheroids
6.2.2.1.1. Micropatterned Plates
6.2.2.1.2. Low Cell Attachment Plates
6.2.2.1.3. Hanging Drop Method
6.2.2.1.4. Others

7.1. Key Insights

7.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
7.2.1. Organoids
7.2.1.1. Primary Tissues
7.2.1.2. Stem Cells
7.2.2. Spheroids
7.2.2.1. Cell Line
7.2.2.2. Primary Cell
7.2.2.3. iPSCs Derived Cell

8.1. Key Insights

8.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
8.2.1. Developmental Biology
8.2.2. Personalized Medicine
8.2.3. Regenerative Medicine
8.2.4. Disease Pathology Studies
8.2.5. Drug Toxicity & Efficacy Testing

9.1. Key Insights

9.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
9.2.1. Biotechnology and pharmaceutical industries
9.2.2. Academic & Research Institutes
9.2.3. Hospitals and diagnostic centers

10.1. Key Insights

10.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
10.2.1. North America
10.2.1.1. The U.S.
10.2.1.2. Canada
10.2.1.3. Mexico
10.2.2. Europe
10.2.2.1. Western Europe
10.2.2.1.1. The UK
10.2.2.1.2. Germany
10.2.2.1.3. France
10.2.2.1.4. Italy
10.2.2.1.5. Spain
10.2.2.1.6. Rest of Western Europe
10.2.2.2. Eastern Europe
10.2.2.2.1. Poland 
10.2.2.2.2. Russia
10.2.2.2.3. Rest of Eastern Europe
10.2.3. Asia Pacific
10.2.3.1. China
10.2.3.2. India
10.2.3.3. Japan
10.2.3.4. South Korea
10.2.3.5. Australia & New Zealand
10.2.3.6. ASEAN
10.2.3.7. Rest of Asia Pacific
10.2.4. Middle East & Africa
10.2.4.1. UAE
10.2.4.2. Saudi Arabia
10.2.4.3. South Africa
10.2.4.4. Rest of MEA
10.2.5. South America
10.2.5.1. Argentina
10.2.5.2. Brazil
10.2.5.3. Rest of South America

11.1. Key Insights

11.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
11.2.1. By Type
11.2.2. By Method
11.2.3. By Source
11.2.4. By Application
11.2.5. By End Use
11.2.6. By Country

12.1. Key Insights

12.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
12.2.1. By Type
12.2.2. By Method
12.2.3. By Source
12.2.4. By Application
12.2.5. By End Use
12.2.6. By Country

13.1. Key Insights

13.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
13.2.1. By Type
13.2.2. By Method
13.2.3. By Source
13.2.4. By Application
13.2.5. By End Use
13.2.6. By Country

14.1. Key Insights

14.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
14.2.1. By Type
14.2.2. By Method
14.2.3. By Source
14.2.4. By Application
14.2.5. By End Use
14.2.6. By Country

15.1. Key Insights

15.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
15.2.1. By Type
15.2.2. By Method
15.2.3. By Source
15.2.4. By Application
15.2.5. By End Use
15.2.6. By Country

16.1. Key Insights

16.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
16.2.1. By Type
16.2.2. By Method
16.2.3. By Source
16.2.4. By Application
16.2.5. By End Use

17.1. Key Insights

17.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
17.2.1. By Type
17.2.2. By Method
17.2.3. By Source
17.2.4. By Application
17.2.5. By End Use

18.1. Key Insights

18.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
18.2.1. By Type
18.2.2. By Method
18.2.3. By Source
18.2.4. By Application
18.2.5. By End Use

19.1. Key Insights

19.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
19.2.1. By Type
19.2.2. By Method
19.2.3. By Source
19.2.4. By Application
19.2.5. By End Use

20.1. Key Insights

20.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
20.2.1. By Type
20.2.2. By Method
20.2.3. By Source
20.2.4. By Application
20.2.5. By End Use

21.1. Key Insights

21.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
21.2.1. By Type
21.2.2. By Method
21.2.3. By Source
21.2.4. By Application
21.2.5. By End Use

22.1. Key Insights

22.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
22.2.1. By Type
22.2.2. By Method
22.2.3. By Source
22.2.4. By Application
22.2.5. By End Use

23.1. Key Insights

23.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
23.2.1. By Type
23.2.2. By Method
23.2.3. By Source
23.2.4. By Application
23.2.5. By End Use

24.1. Key Insights

24.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
24.2.1. By Type
24.2.2. By Method
24.2.3. By Source
24.2.4. By Application
24.2.5. By End Use

25.1. Key Insights

25.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
25.2.1. By Type
25.2.2. By Method
25.2.3. By Source
25.2.4. By Application
25.2.5. By End Use

26.1. Key Insights

26.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
26.2.1. By Type
26.2.2. By Method
26.2.3. By Source
26.2.4. By Application
26.2.5. By End Use

27.1. Key Insights

27.2. Market Size and Forecast, 2019 - 2032 (US$ Mn)
27.2.1. By Type
27.2.2. By Method
27.2.3. By Source
27.2.4. By Application
27.2.5. By End Use

28.1. 3D BioMatrix
28.2. 3D Biotek LLC
28.3. AMS Biotechnology (Europe) Limited
28.4. ATCC
28.5. Cellesce Ltd
28.6. Corning Incorporated
28.7. Greiner Bio-One
28.8. Hubrecht Organoid Technology (HUB)
28.9. InSphero/Perkin Elmer
28.10. Kuraray
28.11. Lonza
28.12. Merck KGaA
28.13. Prellis Biologics
28.14. STEMCELL Technologies Inc.
28.15. Thermo Fisher Scientific, Inc.
28.16. Other Prominent Players.